The abstract is read at the publisher; the summary is JClub's.
In 1158 FINGER trial participants, plasma NULISAseq profiling linked TREM2 and nine other proteins to poorer cognitive trajectories, independent of the lifestyle intervention.
- Why it matters: The FINGER trial shows cognitive benefits for at-risk older adults, but the circulating biological mechanisms and response markers are not well defined.
- What they did: Using the NULISAseq CNS disease panel, investigators measured neurodegeneration-related proteins and tested associations with cognitive trajectories and intervention response, including Elastic Net modeling.
- The result: The intervention altered eight proteins (including CRH, IL-7, and MME) and modified response for eleven proteins, with KDR and CRH strongest; Elastic Net highlighted CRH, PTN, and CCL2, plus APOE ε4- and sex-specific effects.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.